Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?

MLA

Woodard, Gavitt A., et al. “Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-Responders: A Biomarker of T-Cell Dysfunction and Prognosis?” Annals of Surgical Oncology, vol. 31, no. 1, Jan. 2024, pp. 25–27. EBSCOhost, https://doi.org/10.1245/s10434-023-14388-1.

APA

Woodard, G. A., Cho, C., & Chen, L. (2024). Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis? Annals of Surgical Oncology, 31(1), 25–27. https://doi.org/10.1245/s10434-023-14388-1

Chicago

Woodard, Gavitt A, Christina Cho, and Lieping Chen. 2024. “Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-Responders: A Biomarker of T-Cell Dysfunction and Prognosis?” Annals of Surgical Oncology 31 (1): 25–27. doi:10.1245/s10434-023-14388-1.